Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
15 Results for "
incretin hormone
" in MedChemExpress (MCE) Product Catalog:
Products (15)
15 Results for "incretin hormone" in MCE Product Catalog:
11
11 Publications Verification
Cat. No.: HY-P0054A
CAS No.: 107444-51-9
Synonyms: Glucagon-like peptide-1 (GLP-1)(7-36), amide; Human GLP-1 (7-36), amide
Target:
Research Areas:
3
3 Cited Publications
Cat. No.: HY-P0276
CAS No.: 100040-31-1
Synonyms: Gastric Inhibitory Peptide (GIP), human
Target:
Research Areas:
3
Target:
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P70239
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GCG; Glicentin-Related Polypeptide; Glucagon; Glucagon-Like Peptide 1; GLP-1; Glucagon-Like Peptide 2; GLP1; Preproglucagon; GLP2; Pro-Glucagon; GRPP; incretin
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P2080B
Target:
Research Areas:
1
Cat. No.: HY-P4843
CAS No.: 1139691-72-7
Target:
Research Areas:
Cat. No.: HY-P1226
CAS No.: 926018-45-3
Target:
Research Areas:
Cat. No.: HY-P2080
CAS No.: 198624-01-0
Target:
Research Areas:
Cat. No.: HY-120493A
CAS No.: 1449742-87-3
Target:
Research Areas:
AM-6226 is a potent and orally active G protein coupled receptor 40 (GPR40) full agonist with an EC50 of 0.12 μM. AM-6226 can activate the GPR40 receptors on pancreatic β cells and enteroendocrine L cells, promote insulin secretion in a glucose-dependent manner and also increase the release of incretin hormones (GLP-1, GIP), thereby avoiding the risk of hypoglycemia. AM-6226 can be used for the research of metabolic disease, such as diabetes .
Cat. No.: HY-P2080C
Target:
Research Areas:
Cat. No.: HY-P74125A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GIP; Glucose-Dependent Insulinotropic Polypeptide; Gastric Inhibitory Polypeptide; incretin hormone
Species:
Human
Source:
HEK293
Cat. No.: HY-156073
CAS No.: 1998714-25-2
Research Areas:
LY3325656 is a selective GPR142 receptor agonist. LY3325656 selectively activates GPR142 in humans and mice. LY3325656 enhances glucose-dependent insulin secretion, glucagon secretion, as well as the secretion of incretin hormones GLP-1 and GIP. LY3325656 can be used in research related to type 2 diabetes .
Cat. No.: HY-120493
CAS No.: 1142222-28-3
Target:
Research Areas:
(rel)-AM-6226 is the relative stereoisomer of AM-6226 (HY-120493A). AM-6226 is a potent, orally active full agonist of G protein-coupled receptor 40 (GPR40) with an EC50 value of 0.12 μM. AM-6226 activates GPR40 receptors on pancreatic β-cells and enteroendocrine L-cells, promotes insulin secretion in a glucose-dependent manner, and increases the release of incretin hormones (GLP-1, GIP), thus avoiding the risk of hypoglycemia. AM-6226 can be used in the research of metabolic diseases such as diabetes .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
